Evidence map›Paper›PMID 36307213›Full record

ArticleCold Spring Harbor molecular case studies2022

A novel large in-frame

Sümeyye Elgaz, Boris Wittekindt, Anoosh Esmaeili, Sebastian Fischer, Hanno J Bolz, Ulrich Zechner, Horst Buxmann

Open access · greenAbstract readCase Reports
In one paragraph

Article in Cold Spring Harbor molecular case studies, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sümeyye ElgazDepartment of Neonatology, Clinic for Children and Adolescents, University Hospital, 60590 Frankfurt/Main, Germany.
Boris WittekindtDepartment of Neonatology, Clinic for Children and Adolescents, University Hospital, 60590 Frankfurt/Main, Germany.
Anoosh EsmaeiliPediatric Heart Center of Hessen, Goethe University, 60590 Frankfurt am Main, Germany.
Sebastian FischerInstitute for Diagnostic and Interventional Radiology, University Hospital, 60590 Frankfurt, Germany.
Hanno J BolzSenckenberg Centre for Human Genetics, 60314 Frankfurt/Main, Germany.
Ulrich ZechnerSenckenberg Centre for Human Genetics, 60314 Frankfurt/Main, Germany.
Horst BuxmannDepartment of Neonatology, Clinic for Children and Adolescents, University Hospital, 60590 Frankfurt/Main, Germany.ORCID 0000-0001-6196-9171
Goethe University Frankfurt · DEJohannes Gutenberg University Mainz · DEUniversity Hospital Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonatal Marfan syndrome (nMFS) is a rare and severe form of Marfan syndrome (MFS) with a poor prognosis, that presents with a highly variable phenotype, particularly regarding skeletal, ocular, and cardiovascular manifestations. Mutations in the fibrillin-1 (

Indexed as

Marfan SyndromeAdipokinesExonsFemaleFibrillin-1HumansMutationPhenotypeSequence DeletionAdipokinesFBN1 protein, humanFibrillin-1aortic aneurysmarachnodactylycardiomegalyhyperextensible thumbmicroretrognathiapulmonary hypertensionpulmonary valve defectstricuspid regurgitation

Identifiers

PMID36307213
PMCPMC9632361
OpenAlexW4308062178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.